Open AccessA review on management of gestational trophoblastic neoplasia
Author(s) -
Seyedeh Reyhaneh Yousefi Sharami,
Elham Saffarieh
Publication year - 2020
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_876_19
Subject(s) - medicine , choriocarcinoma , placental site trophoblastic tumor , gestational trophoblastic disease , molar pregnancy , gestational trophoblastic neoplasia , pregnancy , human chorionic gonadotropin , chemotherapy , trophoblast , oncology , gynecology , obstetrics , gestation , placenta , fetus , hormone , biology , genetics
The rare presence of malignant cancerous cells afar any type of pregnancy is known as gestational trophoblastic neoplasia (GTN). GTN are benign lesions which mostly happen due to the activity of extravillous trophoblast cells and the placental villous tree development. These kinds of diseases would be occurring mainly due to the following clinicopathologic conditions: (I) existence of epithelioid trophoblastic tumor (ETT), (II) rare type of choriocarcinoma cancer, (III) gestational trophoblastic tumor of mole, and (IV) the rare malignant tumor of placental site trophoblastic tumor.